Other
Journal
Recent Headlines
Thursday, May 23
Positive Phase III Results for Extended-Release Topiramate in Epilepsy Patients
AHA Statement: Costs to Treat Stroke in U.S. May Double by 2030
New Approach for Influenza Vaccination Shows Promise in Early Testing
FDA Advisors Back New Sleep Drug, Suvorexant
Study: 3D Mammography Reduces Recall Rates
Wednesday, May 22
Vitamin C Kills Drug-Resistant TB
Survey: Emerging Agents Offer Advantages Over Current Breast Cancer Therapies
Positive Phase III Results With Simeprevir in Hepatitis Patients
NIH Funds Studies to Improve Prediabetes and Type 2 Diabetes Treatment
Doctors and Hospitals’ Use of Health IT Has Doubled Since 2012
Tuesday, May 21
Improved Quality of Life Is Major Unmet Need in COPD Treatment, Survey Finds
Another Kink in Health Care Law: How Will the ‘Unbanked’ Buy Insurance?
Positive Phase III Results With Sublingual Sufentanil in Management of Postoperative Pain
Multiple Sclerosis Drug Plegridy (Peginterferon) Submitted for FDA Review
Monday, May 20
iPhone App Helps Diagnose Heart Attacks
Feds Make It Easier for States to Enroll Poor Under Health Law
Vitamin D Could Provide New Treatments for Asthma
Study Finds Older Whooping Cough Vaccine More Effective Than Newer Version
Multiple Sclerosis Drug Fails Phase III Trial
Friday, May 17
Study: Depression Doubles Stroke Risk in Middle-Aged Women
Breast Cancer Drug, EndoTAG-1, Shows Promise in Phase II Trial
Nanotechnology Could Help Fight Diabetes, Scientists Say
Positive Phase III Results for Myelofibrosis Treatment
Physical and Emotional Impairments Often Untreated in Cancer Patients
Thursday, May 16
Researchers Identify U.S. ‘Hotspots’ for Infection and Sepsis-Related Mortality
Arthritis Drug Simponi (Golimumab) Gets Expanded Indication for Ulcerative Colitis
FDA Approves Radium Drug Xofigo for Metastatic Prostate Cancer
Positive Phase III Data for New Leukemia Drug, Obinutuzumab
AHA Report: Risk of Hospital Readmission Prolonged After Heart Attack, Heart Failure
Wednesday, May 15
FDA Approves Diagnostic Test for Lung Cancer
Study: Treatment With Two Osteoporosis Drugs Better Than Either Drug Alone
Scientists Develop ‘Magic Bullet’ for Acute Lung Injury
Positive Phase II Results Reported for Ovarian Cancer Vaccine
Administration Allocates $1 Billion for ‘Health Care Innovation Awards’
Tuesday, May 14
Flu in Pregnancy May Quadruple Child's Risk for Bipolar Disorder
Saturday, May 11
Advance Directives Can Reduce End-of-Life Medical Costs, Authors Say
Liver Transplantation for Hepatocellular Carcinoma in HIV-Infected Patients
Cocaine Vaccine Passes Key Hurdle
Thursday, May 9
FDA Alert: Lack of Sterility Assurance for Drug Products From ‘The Compounding Shop’
Wednesday, May 8
All Hospitals Should Require Drug, Alcohol Tests for Physicians
Report: Market for Pancreatic Cancer Therapies Expected to Double to $1.3 Billion Over Next Decade
CDC: Only Half of Americans With Hepatitis C Are Properly Tested
New Vaccine Candidate for Deadly H7N9 Flu Virus
Administration Offers Consumers a Look at Hospital Charges
Tuesday, May 7
AHA Statement: Understanding Heart Patients’ Quality of Life Can Improve Outcomes
FDA Warns Against Use of Migraine Prevention Drugs in Pregnant Women
Alzheimer’s Drug Fails Phase III Study
Survey: Prescription Drug Costs Among Top Concerns for Medicare Beneficiaries
New Lung Cancer Guidelines Recommend Screening for High-Risk Individuals
Monday, May 6
FDA Approves Liptruzet (Ezetimibe/Atorvastatin) to Lower Cholesterol
Report: State Spending Could Have ‘Huge Impact’ on Implementation of Health Care Law
Physicians Expect Xtandi (Enzalutamide) to Become Treatment Leader for Metastatic Prostate Cancer
New Guidelines for Managing Fibromyalgia
FDA Warning: Nonproprietary Name for Breast Cancer Drug Could Cause Medication Errors
